Clinical Trials on Dyslipoproteinaemia in Hong Kong
Total 0 results
Nothing found
Sponsors and Collaborators
- Paulo Sérgio Gomes Nogueira Borges
- Lilly PharmaceuticalCompany
- Foundation for Biosanitary Research and Innovation in Primary Health Care
- Gunkang Pharmaceuticals, Inc
- Korea Otsuka International Asia Arab
- Sudimplant SAS - Groupe TBR
- Cardiovascular Center Dedinje, Belgrade, Serbia
- United States Department of Defense (DOD)
- Klinik für Allgemein- und Viszeralchirurgie, Department Chirurgie, Luzerner Kantonsspital
- Plethora Solutions Ltd
- University of Applied Sciences Jena
- Eurotrials Brasil Consultores Cientificos Ltda
- Julian Taylor Green
- Iyad Naeem Muhammad, PhD
- 904 Hospital of the People's Liberation Army Joint Logistic Support Force
- Arsha Vidya Tirtha
- Oblikue Consulting
- Foshan Sanshui District People's Hospital
- Rivierduinen, Centre for Personality disorders Jelgersma
- S-Biotek Holding ApS
- View Full List
Medical Conditions
- Visual Attention Span Deficit
- Puberty, Delayed
- Chemotherapy-Induced Neutropenia
- Blepharospasm of Both Eyelids
- Advance Directive Completion
- Malaria,Falciparum
- Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)
- Immunologically-induced Lung Disease
- Anemia Acute
- Vibration; Exposure
- Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
- Testicular Teratoma
- Thyroid and Parathyroid Surgery
- Brain Tumor, Primary
- Post-discharge Pharmacist Counseling to Prevent Readmissions
- Serum Albumin Low
- Hypothermia Following Anesthesia, Sequela
- Huntington Chorea
- Deformity Flexion
- Gray Platelet Syndrome
- View Full List
Drug Interventions
- ABY-035 i.v.
- Pemetrexed
- Celecoxib
- Cyanoacrylate
- Acalabrutinib in combination with VR
- Ebselen
- Pegfilgrastim
- MMV390048 120mg
- Oxycodone
- Sorafenib
- F520
- Standard medical therapy
- Rovalpituzumab tesirine
- Bimatoprost 0.03% eye drops
- Recombinant monoclonal antibody against human epidermal growth factor receptor injection (HS627)
- Vosaroxin
- Mineralocorticoid receptor antagonist
- S-Adenosyl-Methionine
- Furmonertinib 160 mg
- Cytisine
- View Full List
CROs by country
- Contract Research Organizations in Argentina
- Contract Research Organizations in Belgium
- Contract Research Organizations in Cambodia
- Contract Research Organizations in Cameroon
- Contract Research Organizations in Ecuador
- Contract Research Organizations in Jamaica
- Contract Research Organizations in Kuwait
- Contract Research Organizations in Mauritius
- Contract Research Organizations in Norway
- Contract Research Organizations in Rwanda
- Contract Research Organizations in Serbia
- Contract Research Organizations in Suriname
- Contract Research Organizations in Ukraine
- CRO list by country